Akers Biosciences and MyMD Pharmaceuticals reported that a new study showed rising temperatures during spring and summer months are associated with slower rates of Covid-19 transmission, which is consistent with the seasonal respiratory virus’ behaviour.
Akers Biosciences and Premas Biotech have reported positive proof-of-concept data from animal studies of their PRAK-03202 vaccine candidate against Covid-19.
Akers Biosciences and Premas Biotech have reported positive proof-of-concept data from animal studies of their PRAK-03202 vaccine candidate against Covid-19.